The industry might be asking why would the Department conduct the review after its interpretation of the criteria has already changed? Individual companies might be asking why the new interpretation has not applied to their requests?

Latest Video
New Stories
-
New Zealand's Medsafe and Pharmac directed to explore AI use to expedite access
July 2, 2025 - - Latest News -
New treatment option for early breast cancer at high risk of recurrence
July 2, 2025 - - Latest News -
Expanded listing for Bristol Myers Squibb's PD-1 to include bladder cancer
July 2, 2025 - - Latest News -
The industry backs productivity focus for the Albanese Government's second term
July 2, 2025 - - Latest News -
Wesfarmers Health launches pilot pharmacy format, InstantScripts Pharmacy Health Hub
July 2, 2025 - - Latest News -
Moderna announces positive Phase 3 result for influenza vaccine
July 1, 2025 - - Latest News -
Takeda therapy now available through the PBS for serious viral infection
July 1, 2025 - - Latest News